Intec Pharma Ltd. (NASDAQ: NTEC)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Intec Pharma Ltd. (NASDAQ: NTEC) in connection with the proposed acquisition of the company by Decoy Biosystems, Inc. ("Decoy"). Upon consummation of the transaction, NTEC's shareholders will own approximately 25% of the combined entity, with Decoy shareholders owning approximately 75%. If you own NTEC shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/ntec/
RumbleOn, Inc. (NASDAQ: RMBL)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of